General Dynamics Takes A Hit From Argus

Also, RBC Capital downgrades Immunogen and gives a $7 price target.

http://www.forbes.com/2010/08/27/downgrades-imgn-vsat-gd-marketnewsvideo.html?feed=rss_markets

About the Author

has written 23517 stories on this site.

Copyright © 2010 corporatecommunicationsnews101.com